Stratos Wealth Partners »

Relmada Therapeutics shares owned by Stratos Wealth Partners

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Stratos Wealth Partners from 13F filings

Historical chart of Stratos Wealth Partners investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Stratos Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Stratos Wealth Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $66k 14k 4.65
2023-12-31 $68k 17k 4.14
2023-09-30 $48k 16k 3.00

More positions owned by Stratos Wealth Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Vanguard Index Fds Extend Mkt Etf (VXF)
Ishares Tr Core Msci Intl (IDEV)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Whitehall Fds High Div Yld (VYM)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Stratos Wealth Partners

Top funds holding Relmada Therapeutics

Vanguard Group
Acadian Asset Management
Parsons Capital Management
Opaleye Management
Palo Alto Investors
Franklin Resources
BlackRock
Citadel Advisors
Two Sigma Advisers
Two Sigma Investments
Geode Capital Management
Point72 Asset Management
Deutsche Bank Aktiengesellschaft
Jacobs Levy Equity Management
Bank of America Corporation

View all funds holding Relmada Therapeutics